Price
No data yet.
Social Signal Score
Revenue
$159.93M+204.51%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Matthias Schupp
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 1,337
- Beta
- 1.17
- Country
- CH
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 3.40
Financials
Revenue
$159.93M+204.5%Net Income
$5.09M+1075.8%EBITDA
$28.09M+250.5%Free Cash Flow
$-10.23M-1020.7%EPS (diluted)
$0.41+1008.1%Shares Outstanding (diluted)
12.47M+6.2%Operating Expenses
$117.63MCash & Debt
$25.66MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $269.26M | $8.35M | $0.67 |
| 2024 | $224.83M | $3.53M | $0.26 |
| 2023 | $212.01M | $619.0K | $0.05 |
| 2022 | $182.82M | $-5.78M | $-0.49 |
| 2021 | $159.88M | $6.84M | $0.58 |
| 2020 | $127.65M | $-943.6K | $-0.08 |
| 2019 | $130.14M | $2.15M | $0.18 |
| 2018 | $121.32M | $4.20M | $0.40 |
| 2017 | $105.04M | $866.5K | $0.07 |
| 2016 | $92.50M | $3.31M | $0.28 |
| 2015 | $82.30M | $7.27M | $0.62 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from MDRSF's reported EPS growth of 0.8% a year over 10 years.
- EPS in 5 years
- $0.70
- Implied price
- $12.60
- Return from $115.00
- -35.7% a year
To earn 15.0% a year on these assumptions you'd need to buy at $6.26 — -94.6% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 15 | 18 | 21 | 24 |
|---|---|---|---|---|---|
| -9.2% | -46.6% | -44.2% | -42.1% | -40.3% | -38.7% |
| -4.2% | -43.7% | -41.1% | -38.9% | -37.0% | -35.3% |
| 0.8% | -40.7% | -38.0% | -35.7% | -33.7% | -31.9% |
| 5.8% | -37.8% | -35.0% | -32.6% | -30.4% | -28.6% |
| 10.8% | -34.9% | -31.9% | -29.4% | -27.2% | -25.2% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
120Social Signal Score
Mentions (1)
- Newsseekingalpha.com·19h ago·Positive
Medartis Holding AG (MDRSF) Q2 2026 Press Conference Call Transcript Medartis Holding AG (MDRSF) Q2 2026 Press Conference Call Transcript
View source ↗
Earnings
Tue, Mar 2(in 6 months)
Estimates and results for MDRSF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.